Home/Filings/4/0001493152-23-032829
4//SEC Filing

Ng Carey 4

Accession 0001493152-23-032829

CIK 0001873835other

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 6:27 PM ET

Size

6.0 KB

Accession

0001493152-23-032829

Insider Transaction Report

Form 4
Period: 2023-09-14
Ng Carey
Director
Transactions
  • Purchase

    Common Stock

    2023-09-14$2.58/sh+10,000$25,76010,000 total
Holdings
  • Common Stock

    (indirect: See footnote)
    1,025,221
Footnotes (2)
  • [F1]This transaction was executed in multiple trades at prices ranging from $2.51 to $2.60, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]Carey Ng is the Managing Director of Mesa Verde Venture Partners III, LP ("Mesa Verde") and in such capacity has the right to vote and dispose of the securities held by such entity.

Documents

1 file

Issuer

Immix Biopharma, Inc.

CIK 0001873835

Entity typeother

Related Parties

1
  • filerCIK 0001889522

Filing Metadata

Form type
4
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 6:27 PM ET
Size
6.0 KB